Patents by Inventor Piero Pileri

Piero Pileri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10359428
    Abstract: Newly identified proteins as markers for the detection of colon, ovary, kidney, esophagus and prostate tumors, or as therapeutic targets for their treatment; affinity ligands and particularly antibodies capable of selectively interacting with the tumor markers and methods for tumor diagnosis and therapy using such antibodies.
    Type: Grant
    Filed: June 13, 2014
    Date of Patent: July 23, 2019
    Assignee: EXTERNAUTICS S.P.A.
    Inventors: Renata Grifantini, Piero Pileri, Susanna Campagnoli, Alberto Grandi, Matteo Parri, Jin Boquan
  • Patent number: 10288617
    Abstract: Newly identified proteins as markers for the detection of ovary tumors, or as therapeutic targets for treatment thereof; affinity ligands capable of selectively interacting with the newly identified markers, methods for tumor diagnosis and therapy using the same.
    Type: Grant
    Filed: October 26, 2010
    Date of Patent: May 14, 2019
    Assignee: Externautics Spa
    Inventors: Renata Grifantini, Piero Pileri, Susanna Campagnoli, Alberto Grandi, Matteo Parri, Andrea Pierleoni, Renzo Nogarotto
  • Publication number: 20180313841
    Abstract: Newly identified proteins as markers for the detection of ovary tumors, or as therapeutic targets for treatment thereof; affinity ligands capable of selectively interacting with the newly identified markers, methods for tumor diagnosis and therapy using the same.
    Type: Application
    Filed: March 27, 2018
    Publication date: November 1, 2018
    Inventors: Renata Grifantini, Piero Pileri, Susanna Campagnoli, Alberto Grandi, Matteo Parri, Andrea Pierleoni, Renzo Nogarotto
  • Publication number: 20170227543
    Abstract: Newly identified proteins as markers for the detection of breast tumors, or as therapeutic targets for treatment thereof; affinity ligands capable of selectively interacting with the newly identified markers, as well as methods for tumor diagnosis and therapy using such ligands.
    Type: Application
    Filed: October 31, 2016
    Publication date: August 10, 2017
    Applicant: Externautics SpA
    Inventors: Renata Grifantini, Piero Pileri, Susanna Campagnoli, Alberto Grandi, Matteo Parri, Andrea Pierleoni, Renzo Nogarotto
  • Publication number: 20160131656
    Abstract: Newly identified proteins as markers for the detection of colon, ovary, kidney, esophagus and prostate tumors, or as therapeutic targets for their treatment; affinity ligands and particularly antibodies capable of selectively interacting with the tumor markers and methods for tumor diagnosis and thereapy using such antibodies.
    Type: Application
    Filed: June 13, 2014
    Publication date: May 12, 2016
    Inventors: Renata Grifantini, Piero Pileri, Susanna Campagnoli, Alberto Grandi, Matteo Parri, Jin Boquan
  • Patent number: 9182404
    Abstract: The invention provides newly identified proteins as markers for the detection of tumors, or as targets for their treatment, particularly of tumors affecting lung, colon, breast, ovary; affinity ligands capable of selectively interacting with the newly identified markers; methods of screening a tissue sample for malignancy, for determining the presence of a tumor in a subject and for screening a test compound as an antitumor candidate; a diagnostic kit.
    Type: Grant
    Filed: January 27, 2010
    Date of Patent: November 10, 2015
    Assignee: EXTERNAUTICS S.P.A.
    Inventors: Renata Grifantini, Piero Pileri, Susanna Campagnoli, Andrea Pierleoni, Renzo Nogarotto
  • Publication number: 20150093396
    Abstract: Newly identified proteins as markers for the detection of prostate tumors, or as targets for their therapeutic treatment, affinity ligands capable of selectively interacting with said markers as well as methods for tumor diagnosis and therapy using the same.
    Type: Application
    Filed: December 5, 2014
    Publication date: April 2, 2015
    Inventors: Renata Grifantini, Piero Pileri, Susanna Campagnoli, Alberto Grandi, Matteo Parri, Andrea Pierleoni, Renzo Nogarotto
  • Patent number: 8921058
    Abstract: Newly identified proteins as markers for the detection of prostate tumors, or as targets for their therapeutic treatment, affinity ligands capable of selectively interacting with said markers as well as methods for tumor diagnosis and therapy using the same.
    Type: Grant
    Filed: October 26, 2010
    Date of Patent: December 30, 2014
    Assignee: Externautics SpA
    Inventors: Renata Grifantini, Piero Pileri, Susanna Campagnoli, Alberto Grandi, Matteo Parri, Andrea Pierleoni, Renzo Nogarotto
  • Publication number: 20130137106
    Abstract: Newly identified proteins as markers for the detection of breast, colon, lung and ovary tumors, or as therapeutic targets for their treatment, affinity ligands capable of selectively interacting with the newly identified markers and methods for tumor diagnosis and therapy using such ligands.
    Type: Application
    Filed: April 29, 2011
    Publication date: May 30, 2013
    Applicant: EXTERNAUTICS S.P.A.
    Inventors: Renata Grifantini, Piero Pileri, Susanna Campagnoli, Matteo Parri, Alberto Grandi, Andrea Pierleoni
  • Publication number: 20130022983
    Abstract: Newly identified proteins as markers for the detection of colon and rectal tumors, or as therapeutic targets for treatment thereof; affinity ligands capable of selectively interacting with the newly identified markers, as well as methods for tumor diagnosis and therapy using such ligands.
    Type: Application
    Filed: October 26, 2010
    Publication date: January 24, 2013
    Applicant: EXTERNAUTICS S.P.A.
    Inventors: Renata Grifantini, Piero Pileri, Susanna Campagnoli, Alberto Grandi, Matteo Parri, Andrea Pierleoni, Renzo Nogarotto
  • Publication number: 20130017546
    Abstract: Newly identified proteins as markers for the detection of breast tumors, or as therapeutic targets for treatment thereof; affinity ligands capable of selectively interacting with the newly identified markers, as well as methods for tumor diagnosis and therapy using such ligands.
    Type: Application
    Filed: October 26, 2010
    Publication date: January 17, 2013
    Applicant: Externautics S.P.A.
    Inventors: Renata Grifantini, Piero Pileri, Susanna Campagnoli, Alberto Grandi, Matteo Parri, Andrea Pierleoni, Renzo Nogarotto
  • Publication number: 20130004955
    Abstract: Newly identified proteins as markers for the detection of ovary tumors, or as therapeutic targets for treatment thereof; affinity ligands capable of selectively interacting with the newly identified markers, methods for tumor diagnosis and therapy using the same.
    Type: Application
    Filed: October 26, 2010
    Publication date: January 3, 2013
    Applicant: EXTERNAUTICS S.P.A.
    Inventors: Renata Grifantini, Piero Pileri, Susanna Campagnoli, Alberto Grandi, Matteo Parri, Andrea Pierleoni, Renzo Nogarotto
  • Publication number: 20120322074
    Abstract: Newly identified proteins as markers for the detection of prostate tumors, or as targets for their therapeutic treatment, affinity ligands capable of selectively interacting with said markers as well as methods for tumor diagnosis and therapy using the same.
    Type: Application
    Filed: October 26, 2010
    Publication date: December 20, 2012
    Applicant: EXTERNAUTICS S.P.A.
    Inventors: Renata Grifantini, Piero Pileri, Susanna Campagnoli, Alberto Grandi, Matteo Parri, Andrea Pierleoni, Renzo Nogarotto
  • Publication number: 20120322075
    Abstract: Newly identified proteins as markers for the detection of lung tumors, or as therapeutic targets for their treatment, affinity ligands capable of selectively interacting with the newly identified markers and methods for tumor diagnosis and therapy using such ligands.
    Type: Application
    Filed: October 26, 2010
    Publication date: December 20, 2012
    Applicant: EXTERNAUTICS S.P.A.
    Inventors: Renata Grifantini, Piero Pileri, Susanna Campagnoli, Alberto Grandi, Matteo Parri, Andrea Pierleoni, Renzo Nogarotto
  • Publication number: 20120052071
    Abstract: The invention provides newly identified proteins as markers for the detection of tumors, or as targets for their treatment, particularly of tumors affecting lung, colon, breast, ovary; affinity ligands capable of selectively interacting with the newly identified markers; methods of screening a tissue sample for malignancy, for determining the presence of a tumor in a subject and for screening a test compound as an antitumor candidate; a diagnostic kit.
    Type: Application
    Filed: January 27, 2010
    Publication date: March 1, 2012
    Applicant: Externautics S.p.A.,
    Inventors: Renata Grifantini, Piero Pileri, Susanna Campagnoli, Andrea Pierleoni, Renzo Nogarotto
  • Publication number: 20120045439
    Abstract: The invention provides newly identified proteins as markers for the detection of tumors, or as targets for their treatment, particularly of tumors affecting lung, colon, breast, ovary; affinity ligands capable of selectively interacting with the newly identified markers; methods of screening a tissue sample for malignancy, for determining the presence of a tumor in a subject and for screening a test compound as an antitumor candidate; a diagnostic kit.
    Type: Application
    Filed: January 27, 2010
    Publication date: February 23, 2012
    Applicant: EXTERNAUTICS S.P.A.,
    Inventors: Renata Grifantini, Piero Pileri, Susanna Campagnoli, Andrea Pierleoni, Renzo Nogarotto
  • Patent number: 7807438
    Abstract: The invention relates to a method for isolation of hepatitis C virus. The method comprises the separation of particles termed exosomes from the blood plasma of an individual infected with hepatitis C virus (HCV) and the extraction or RNA from these exosome particles.
    Type: Grant
    Filed: January 30, 2007
    Date of Patent: October 5, 2010
    Assignee: Novartis AG
    Inventors: Sergio Abrignani, Piero Pileri
  • Publication number: 20070254351
    Abstract: The invention relates to a method for isolation of hepatitis C virus. The method comprises the separation of particles termed exosomes from the blood plasma of an individual infected with hepatitis C virus (HCV) and the extraction or RNA from these exosome particles.
    Type: Application
    Filed: January 30, 2007
    Publication date: November 1, 2007
    Inventors: Sergio Abrignani, Piero Pileri
  • Patent number: 7198923
    Abstract: The invention relates to a method for the isolation of hepatitis C virus. The method comprises the separation of particles termed exosomes from the blood plasma of an individual infected with hepatitis C virus (HCV) and the extraction or RNA from these exosome particles.
    Type: Grant
    Filed: November 20, 2000
    Date of Patent: April 3, 2007
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Sergio Abrignani, Piero Pileri
  • Patent number: 4957736
    Abstract: The invention is concerned with the use of a compound analogous to tuftsin, having the formula (I) ##STR1## or of a pharmaceutically acceptable base-addition or acid-additon salt thereof, as an adjuvant in order to potentiate, in a living organism, the antibody response against either natural or synthetic antigens, as well as with the novel compositions for vaccines which comprise one or more of said antigens together with an adjuvating amount of the compound of formula (I) or of one of its addition salts.
    Type: Grant
    Filed: May 26, 1989
    Date of Patent: September 18, 1990
    Assignee: Sclavo S.p.A.
    Inventors: Luciano Nencioni, Piero Pileri, Samuele Peppoloni, Sergio Silvestri